MedPath
NMPA Approval

Pembrolizumab injection

国药准字SJ20180019

December 22, 2022

S20180019

Drug Information

帕博利珠单抗注射液

可瑞达

注射剂

100mg/4ml

生物制品

December 22, 2022

December 21, 2027

Company Information

Applicant Company

Merck, Inc.

126 E. Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065 United States of America

Manufacturing Company

msd ireland (carlow)

Dublin Road, County Carlow, Carlow, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕博利珠单抗注射液 - NMPA 批准文号 | MedPath